U.S. Military Gives Iran a Taste of Its Own Drones Today
The Pentagon has begun using low-cost drones modeled after Iran’s Shahed systems in recent strikes, raising questions...
Wealth Building Strategies For The Future
Uncover wealth-building strategies for the future. Take actionable steps today to secure your financial well-being.
19,884 articles
Prediction-Market Traders Betting Iran’s Fate: Fine Print Reminder
Prediction-market trading on Iran’s leadership surged as tensions flared, but unverified rumors triggered rapid price...
Facing Backlash: OpenAI’s Altman Regrets Pentagon Deal
OpenAI’s Sam Altman apologized for sloppy wording in announcing a Pentagon contract, pledging a revised release to em...
Most Feared Tanks Second: How War Machines Move Defense Stocks
As geopolitical risk stays elevated, investors are reevaluating defense allocations. Lessons from WWII’s most feared ...
NVIDIA to Include Stock-Based Pay in Non-GAAP Metrics
NVIDIA will begin counting stock-based compensation in non-GAAP results from Q1 FY2027, a shift that rekindles a long...
Taiwan Indicts Over Laundering Tied to Crypto Scam Case
A multi-jurisdictional probe led to indictments for 62 people connected to a massive crypto-laundering operation. The...
ChargePoint (CHPT) 2026 Earnings Outlook for Investors
As electric-vehicle charging scales up, ChargePoint's 2026 earnings outlook becomes a key signal for investors. This ...
Intel Stock Dropped More: What Spooked Markets in February?
A sharp February pullback put Intel back in focus. This guide breaks down the drivers, the long-term thesis, and how ...
Palantir CoreWeave: Which Is Better for Investors Today
Palantir and CoreWeave are at the center of the AI investment wave. This guide breaks down which is better for your p...
Zuckerberg Pushes Back on Addictive Claims at NM Trial
In a high-stakes New Mexico trial, Mark Zuckerberg argues that Facebook and Instagram are not designed to be addictiv...
This Next-Gen Obesity Drug: Can It Save Novo Nordisk?
Novo Nordisk faces intense pressure in the fast-growing obesity treatment space. This article dives into whether this...
Is It Still Worth Buying GSK After a 46% Rally in Shares This Year
GSK has seen a steep run in its stock, prompting questions about whether the rally still offers upside. This article ...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Time To Notice Score Change After Secured Card
Secured Card Reported To Credit Bureaus Instantly